drugset
drugset / Trial / NCT02520934

Miglustat on Gaucher Disease Type IIIB

NCT02520934 ↗

Unknown 19 enrolled National Taiwan University Hospital Actelion · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

evaluate the combination therapy with Miglustat and enzyme replacement therapy (ERT) on Gaucher disease

Timeline

Start
2015-07
Primary completion
2017-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglustat Small molecule — —

Indications

Gaucher disease